 Tobacco use disorder and bipolar disorders are top of the causes of disability and mortality worldwide. The aim of this study was to evaluate N-acetyl-cysteine NAC as an adjunctive treatment in patients with Tobacco use disorder with comorbid bipolar disorder N72 NACplacebo recruited from outpatients smoking cessation unit at Londrina State University, Brazil. 